|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jayaraman S and Jarnagin WR: Management of
gallbladder cancer. Gastroenterol Clin North Am. 39:331–342. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reid KM, Ramos-De la Medina A and Donohue
JH: Diagnosis and surgical management of gallbladder cancer: A
review. J Gastrointest Surg. 11:671–681. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hawkins WG, DeMatteo RP, Jarnagin WR,
Ben-Porat L, Blumgart LH and Fong Y: Jaundice predicts advanced
disease and early mortality in patients with gallbladder cancer.
Ann Surg Oncol. 11:310–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ootani T, Shirai Y, Tsukada K and Muto T:
Relationship between gallbladder carcinoma and the segmental type
of adenomyomatosis of the gallbladder. Cancer. 69:2647–2652. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roa JC, Tapia O, Cakir A, Basturk O,
Dursun N, Akdemir D, Saka B, Losada H, Bagci P and Adsay NV:
Squamous cell and adenosquamous carcinomas of the gallbladder:
Clinicopathological analysis of 34 cases identified in 606
carcinomas. Mod Pathol. 24:1069–1078. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park SB, Kim YH, Rho HL, Chae GB and Hong
SK: Primary carcinosarcoma of the gallbladder. J Korean Surg Soc.
82:54–58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu DC and Yang ZL: MTDH and EphA7 are
markers for metastasis and poor prognosis of gallbladder
adenocarcinoma. Diagn Cytopathol. 41:199–205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Giaginis C, Vgenopoulou S, Vielh P and
Theocharis S: MCM proteins as diagnostic and prognostic tumor
markers in the clinical setting. Histol Histopathol. 25:351–370.
2010.PubMed/NCBI
|
|
10
|
MacCallum DE and Hall PA: The biochemical
characterization of the DNA binding activity of pKi67. J Pathol.
191:286–298. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mehrotra P, Gonzalez MA, Johnson SJ,
Coleman N, Wilson JA, Davies BR and Lennard TW: Mcm-2 and Ki-67
have limited potential in preoperative diagnosis of thyroid
malignancy. Laryngoscope. 116:1434–1438. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brown DC and Gatter KC: Ki67 protein: The
immaculate deception? Histopathology. 40:2–11. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Toschi L and Bravo R: Changes in
cyclin/proliferating cell nuclear antigen distribution during DNA
repair synthesis. J Cell Biol. 107:1623–1628. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tachibana KE, Gonzalez MA and Coleman N:
Cell-cycle-dependent regulation of DNA replication and its
relevance to cancer pathology. J Pathol. 205:123–129. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stoeber K, Tlsty TD, Happerfield L, Thomas
GA, Romanov S, Bobrow L, Williams ED and Williams GH: DNA
replication licensing and human cell proliferation. J Cell Sci.
114:2027–2041. 2001.PubMed/NCBI
|
|
16
|
Madine MA, Swietlik M, Pelizon C,
Romanowski P, Mills AD and Laskey RA: The roles of the MCM, ORC,
and Cdc6 proteins in determining the replication competence of
chromatin in quiescent cells. J Struct Biol. 129:198–210. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chatrath P, Scott IS, Morris LS, Davies
RJ, Rushbrook SM, Bird K, Vowler SL, Grant JW, Saeed IT, Howard D,
et al: Aberrant expression of minichromosome maintenance protein-2
and Ki67 in laryngeal squamous epithelial lesions. Br J Cancer.
89:1048–1054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Davies RJ, Freeman A, Morris LS, Bingham
S, Dilworth S, Scott I, Laskey RA, Miller R and Coleman N: Analysis
of minichromosome maintenance proteins as a novel method for
detection of colorectal cancer in stool. Lancet. 359:1917–1919.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sirieix PS, O'Donovan M, Brown J, Save V,
Coleman N and Fitzgerald RC: Surface expression of minichromosome
maintenance proteins provides a novel method for detecting patients
at risk for developing adenocarcinoma in Barrett's esophagus. Clin
Cancer Res. 9:2560–2566. 2003.PubMed/NCBI
|
|
20
|
Zhao J, Zhang X, Shi M, Xu H, Jin J, Ni H,
Yang S, Dai J, Wu M and Guo Y: TIP30 inhibits growth of HCC cell
lines and inhibits HCC xenografts in mice in combination with 5-FU.
Hepatology. 44:205–215. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shtivelman E: A link between metastasis
and resistance to apoptosis of variant small cell lung carcinoma.
Oncogene. 14:2167–2673. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
NicAmhlaoibh R and Shtivelman E:
Metastasis suppressor CC3 inhibits angiogenic properties of tumor
cells in vitro. Oncogene. 20:270–275. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiao H, Palhan V, Yang Y and Roeder RG:
TIP30 has an intrinsic kinase activity required for up-regulation
of a subset of apoptotic genes. EMBO J. 19:956–963. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Zhang Y, Cao S, Chen X, Lu Y, Jin H,
Sun S, Chen B, Liu J, Ding J, et al: Reduction of TIP30 correlates
with poor prognosis of gastric cancer patients and its restoration
drastically inhibits tumor growth and metastasis. Int J Cancer.
124:713–721. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ito M, Jiang C, Krumm K, Zhang X, Pecha J,
Zhao J, Guo Y, Roeder RG and Xiao H: TIP30 deficiency increases
susceptibility to tumorigenesis. Cancer Res. 63:8763–8767.
2003.PubMed/NCBI
|
|
26
|
Nishihara K, Nagai E, Izumi Y, Yamaguchi K
and Tsuneyoshi M: Adenosquamous carcinoma of the gallbladder: A
clinicopathological, immunohistochemical and flow-cytometric study
of twenty cases. Jpn J Cancer Res. 85:389–399. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kondo M, Dono K, Sakon M, Shimizu J,
Nagano H, Nakamori S, Umeshita K, Wakasa K and Monden M:
Adenosquamous carcinoma of the gallbladder. Hepatogastroenterology.
49:1230–1234. 2002.PubMed/NCBI
|
|
28
|
Tye BK: MCM proteins in DNA replication.
Annu Rev Biochem. 68:649–686. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lei M and Tye BK: Initiating DNA synthesis
from recruiting to activating the MCM complex. J Cell Sci.
114:1447–1454. 2001.PubMed/NCBI
|
|
30
|
Zhang H, Zhang Y, Duan HO, Kirley SD, Lin
SX, McDougal WS, Xiao H and Wu CL: TIP30 is associated with
progression and metastasis of prostate cancer. Int J Cancer.
123:810–816. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao J, Ni H, Ma Y, Dong L, Dai J, Zhao F,
Yan X, Lu B, Xu H and Guo Y: TIP30/cc3 expression in breast
carcinoma: Relation to metastasis, clinicopathologic parameters,
and P53 expression. Hum Pathol. 38:293–298. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gakiopoulou H, Korkolopoulou P, Levidou G,
Thymara I, Saetta A, Piperi C, Givalos N, Vassilopoulos I, Ventouri
K, Tsenga A, et al: Minichromosome maintenance 2 and 5 in
non-benign epithelial ovarian tumours: Relationship with cell cycle
regulators and prognostic implications. Br J Cancer. 97:1124–1134.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Reena RM, Mastura M, Siti-Aishan AM,
Munirah MA, Norlia A, Naqiyah I, Rohaizak M and Sharifah NA:
Minichromosome maintenance 2 is a reliable proliferative marker in
breast carcinoma. Ann Diagn Pathol. 12:340–343. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Giaqinis C, Georgiadou M, Dimakopoulou K,
Tsourouflis G, Gatzidou E, Kouraklis G and Theocharis S: Clinical
significance of MCM-2, MCM-5 expression in colon cancer:
Association with clinicopathological parameters and tumor
proliferative capacity. Dig Dis Sci. 54:282–291. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiao H, Tao Y, Greenblatt J and Roeder RG:
A cofactor, TIP30, specifically enhances HIV-1 Tat-activated
transcription. Proc Natl Acad Sci USA. 95:2146–2151. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shtivelman E: A link between metastasis
and resistance to apoptosis of variant small cell lung carcinoma.
Oncogene. 14:2167–2173. 1997. View Article : Google Scholar : PubMed/NCBI
|
